Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome
Amir Lass
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Dear Sir, I read the recent article by van Wely et al. (2003) with great interest. In their meta‐analysis, the authors found and included three studies comparing recombinant FSH (rFSH) with urinary‐derived FSH (uFSH) (Loumaye et al., 1996; Coelingh Bennink et al., 1998; Yarali et al., 1999). To the best of my knowledge, there is no published study directly comparing rFSH with HMG in ovulation induction in general, and in polycystic ovary patients in particular. Therefore, the title ‘Recombinant FSH in alternative doses or versus urinary gonadotrophins…’ may confuse the reader, who assumes that rFSH was evaluated against urinary gonadotrophins or HMG. The true comparison of rFSH versus uFSH was clarified in the abstract and the article, but not in the title. I think it is relevant and important to clarify this point so as not to mislead the casual reader with the all encompassing term ‘urinary gonadotrophins’ when the more specific term ‘urinary FSH’ is more appropriate.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Ovarian function and disorders
Reproductive Health and Technologies · Reproductive Biology and Fertility
参考文献 7
此处列出前 3 条
引用本文 2
按被引量排序,此处列出前 3 条